BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11158873)

  • 1. Nutritional and hormonal control of protein breakdown.
    Combaret L; Taillandier D; Attaix D
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S108-11. PubMed ID: 11158873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms regulating protein turnover in muscle.
    Price SR; Du JD; Bailey JL; Mitch WE
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S112-4. PubMed ID: 11158874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
    Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
    Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.
    Combaret L; Taillandier D; Dardevet D; Béchet D; Rallière C; Claustre A; Grizard J; Attaix D
    Biochem J; 2004 Feb; 378(Pt 1):239-46. PubMed ID: 14636157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.
    Dardevet D; Sornet C; Taillandier D; Savary I; Attaix D; Grizard J
    J Clin Invest; 1995 Nov; 96(5):2113-9. PubMed ID: 7593595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of proteolysis.
    Attaix D; Combaret L; Pouch MN; Taillandier D
    Curr Opin Clin Nutr Metab Care; 2001 Jan; 4(1):45-9. PubMed ID: 11122559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway.
    Mitch WE; Goldberg AL
    N Engl J Med; 1996 Dec; 335(25):1897-905. PubMed ID: 8948566
    [No Abstract]   [Full Text] [Related]  

  • 10. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
    Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
    J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
    Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
    Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
    Hasselgren PO
    Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.
    Kee AJ; Combaret L; Tilignac T; Souweine B; Aurousseau E; Dalle M; Taillandier D; Attaix D
    J Physiol; 2003 Feb; 546(Pt 3):765-76. PubMed ID: 12563002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
    Jagoe RT; Goldberg AL
    Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):183-90. PubMed ID: 11517350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
    Hasselgren PO; Fischer JE
    Ann Surg; 1997 Mar; 225(3):307-16. PubMed ID: 9060588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification.
    Isozaki U; Mitch WE; England BK; Price SR
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1967-71. PubMed ID: 8700868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids.
    Auclair D; Garrel DR; Chaouki Zerouala A; Ferland LH
    Am J Physiol; 1997 Mar; 272(3 Pt 1):C1007-16. PubMed ID: 9124503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
    Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
    Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.
    Wray CJ; Sun X; Gang GI; Hasselgren PO
    J Surg Res; 2002 May; 104(2):82-7. PubMed ID: 12020124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.